Generation of anterior foregut endoderm from pluripotent cells
The invention is directed to in vitro methods of inducing differentiation of anterior foregut endoderm and the enriched populations of anterior foregut endoderm produced by such methods. Such enriched populations are useful for studies of the molecular events that occur during differentiation and for generating cells for cell replacement therapy.
1. A method of deriving an anterior foregut endoderm cell, the method comprising culturing a definitive endoderm cell derived from a pluripotent cell, in the presence of an inhibitor of bone morphogenetic protein (BMP) and in the presence of an inhibitor of transforming growth factor beta (TGF-beta) signaling.
2. The method of claim 1 , wherein the definitive endoderm cell is cultured in the absence of Activin A.
3. The method of claim 1 , wherein the inhibitor of BMP is Noggin, Chordin, or follistatin.
4. The method of claim 3 , wherein the inhibitor of BMP is Noggin.
5. The method of claim 1 , wherein the inhibitor of TGF-beta signaling is SB-431542.
6. The method of claim 2 , wherein the BMP inhibitor is Noggin and the inhibitor of TGF-beta signaling is SB-431542.
7. The method of claim 1 , wherein the definitive endoderm cell is an embryoid body cell.
8. The method of claim 1 , wherein the anterior foregut endoderm cell is a human cell.
9. The method of claim 1 , wherein the pluripotent cell is an embryonic stem cell.
10. The method of claim 1 , wherein the pluripotent cell is an induced pluripotent stem cell.
11. The method of claim 1 , wherein the pluripotent cell is a human cell.
12. The method of claim 1 , wherein the anterior foregut endoderm cell expresses Foxa2 and comprises an elevated level of Sox2 expression and a reduced level of Cdx2 expression, compared to the expression of Sox2 and Cdx2 in the definitive endoderm cell.